SCHEMBL30103286

SCHEMBL30103286

Cn1cc2ccc(OCCN3CCOCC3)cc2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
KDM4E B2RXH2 2/20 0.55
NPC1 O15118 3/20 0.55
FGFR1 P11362 1/20 0.53
SRC P12931 1/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
MAOA P21397 1/20 0.50
ACHE P22303 1/20 0.49
RAB9A P51151 2/20 0.49
SIGMAR1 Q99720 3/20 0.49
HTR2B P41595 2/20 0.49
MAPK1 P28482 2/20 0.49
CYP1A2 P05177 1/20 0.49
CHRM2 P08172 1/20 0.49
CHRM1 P11229 1/20 0.49
HTR2A P28223 1/20 0.49
SCN1A P35498 1/20 0.49
KCNH2 Q12809 1/20 0.49
SCN2A Q99250 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11274158 0.83 ALDH1A1 (0.62) ALDH1A1KDM4ENPC1FGFR1SRC
SCHEMBL28868182 0.78 SIGMAR1 (0.54) ALDH1A1KDM4ESIGMAR1CYP1A2KCNH2
SCHEMBL14570561 0.78 NPC1 (0.65) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL6386440 0.78 KDM4E (0.55) ALDH1A1KDM4ENPC1FGFR1SRC
SCHEMBL4420934 0.77 NPC1 (0.65) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL21642566 0.77 KDM4E (0.65) ALDH1A1KDM4ENPC1FGFR1SRC
SCHEMBL22529608 0.76 MEN1 (0.56) ALDH1A1KDM4ENPC1FGFR1SRC
SCHEMBL22529582 0.76 MEN1 (0.56) ALDH1A1KDM4ENPC1FGFR1SRC
SCHEMBL14149490 0.75 NPC1 (0.62) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL30427229 0.75 MAPT (0.53) ALDH1A1KDM4ENPC1SRCMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448881-A Heteroaryl compound, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2022-12-09 CN disclosed